Concepedia
Statistics
Publications
20
Citations
1.1K
H-Index
16
Active since
1996
Affiliations
Amgen (United States)(Current)
Zhejiang University
San Francisco VA Medical Center
ChemoCentryx (United States)
Liusheng Zhu is an author at Amgen (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.
Publications per year
1996–2018
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies
Sean Caenepeel, Sean P. Brown, Brian Belmontes et al. · Cancer Discovery · 2018 · 419 citations · Full text
Medicine, Oncology, Pharmacology +14
Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3
Michael G. Johnson, An‐Rong Li, Jiwen Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 105 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +12
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist
Sean P. Brown, Paul J. Dransfield, Marc Vimolratana et al. · ACS Medicinal Chemistry Letters · 2012 · 89 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +17
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles
Yingcai Wang, Jiwen Liu, Paul J. Dransfield et al. · ACS Medicinal Chemistry Letters · 2013 · 81 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Discovery and optimization of a novel series of liver X receptor-α agonists
Leping Li, Jiwen Liu, Liusheng Zhu et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 63 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
1–5 of 20